Medicine group | Biguanides | Sulfonylureas | Thiazolidinediones | DPP-4 | Other | Total |
---|---|---|---|---|---|---|
A10BA | A10BB | A10BG | A10BH | A10BC, A10BF, A10BX | n (%) | |
WHO ATC code | n (%) | n (%) | n (%) | n (%) | n (%) | |
Total | 907 125 (51.9) | 527, 886 (30.2) | 25 658 (1.5) | 126 345 (7.2) | 60 069 (3.4) | 1 747 755 (100.0) |
<15 years | 1547 (50.0) | 914 (29.5) | 50 (1.6) | 142 (4.6) | 139 (4.5) | 3096 (0.18) |
15–24 years | 2959 (69.7) | 675 (15.9) | 57 (1.3) | 178 (4.2) | 212(5.0) | 4247 (0.24) |
25–34 years | 12 537 (67.6) | 3020 (16.3) | 247 (1.3) | 734(4.0) | 1088 (5.9) | 18 554 (1.06) |
35–44 | 48 558 (59.3) | 17 542 (21.4) | 1243 (1.5) | 4414 (5.4) | 4787 (5.8) | 81 960 (4.7) |
45–54 years | 125 732 (54.0) | 57 833 (24.8) | 3553 (1.5) | 14 760 (6.3) | 14 168 (6.1) | 232 955 (13.3) |
55–64 years | 236 515 (52.6) | 122 554 (27.3) | 7493 (1.7) | 31 253 (6.9) | 20 675 (4.6) | 449 432 (25.7) |
65–69 years | 140 569 (52.0) | 79 897 (29.6) | 4372 (1.6) | 20 725 (7.7) | 7936 (2.9) | 270 106 (15.5) |
70+ years | 333 853 (49.3) | 242 256 (35.8) | 8435 (1.3) | 53 435 (7.9) | 10 600 (1.6) | 677 401 (38.8) |
Women | 368 707 (53.2) | 204 465 (29.5) | 9450 (1.4) | 49 794 (7.2) | 25 412 (3.7) | 692 565 (39.6) |
Men | 536 766 (51.0) | 322 465 (30.7) | 16 073 (1.5) | 76 275 (7.3) | 34 545 (3.3) | 1 051 910 (60.2) |
Numbers are numbers of prescriptions in 2012.
Other includes sulfonamides, α glucosidase inhibitors and ‘other’ agents as defined by WHO ATC dictionary.
DPP-4, dipeptidyl peptidase-4 inhibitors.